Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>512 µM
Hemolytic
Cytotoxic
50% Hemolysis | >512 | µM | target cell: Horse erythrocytes
Target
Horse erythrocytes
Source & Reference
NA
DBAASP
Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells. | PeerJ | 2018